Status:
UNKNOWN
Supplemental Adjuvants for Intracellular Nutrition and Treatment
Lead Sponsor:
Mid-Atlantic Retina Consultations, Inc.
Collaborating Sponsors:
West Virginia University
Conditions:
Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Eligibility:
All Genders
Phase:
NA
Brief Summary
Nutritional supplements have an augmentative effect on the outcomes of standard treatment of diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).
Detailed Description
It has been shown that in chronic diseases, oxidative stress results from Nitric acid reacting with oxygen to form toxins that damage both somatic and mitochondrial DNA. The potential for protecting t...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of NAMD
- Clinical Diagnosis of DME
Exclusion
- Pregnant Women
- Known allergy to any component used in the treatment combinations
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00893724
Start Date
June 1 2009
End Date
September 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mid-Atlantic Retina Consultations, Inc.
Morgantown, West Virginia, United States, 26505